Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2012

AUTHORS

Rui Gong , Weizao Chen , Dimiter S. Dimitrov

ABSTRACT

Most of the FDA-approved therapeutic monoclonal antibodies are full-size IgG molecules with a molecular weight of about 150 kDa. A major problem for such large molecules is their poor penetration into tissues (e.g., solid tumors) and poor or absent binding to regions on the surface of some molecules (e.g., on the HIV envelope glycoprotein) which are fully accessible only by molecules of smaller size. Therefore, much work especially during the last decade has been aimed at developing novel scaffolds of much smaller size and high stability. Immunoglobulin-based scaffolds including Fab (∼50 kD), ScFv (∼30 kD), and VH domain (termed domain antibody, dAb) (∼15 kD) have been well established. Recently, a new scaffold based on human IgG1 CH2 domain (∼15 kD) was also proposed (termed nanoantibody, nAb). Binders based on a CH2 scaffold could also confer some effector functions. Here, we describe the design, expression, purification, and characterization of engineered CH2 and VH domains. More... »

PAGES

85-102

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-61779-921-1_6

DOI

http://dx.doi.org/10.1007/978-1-61779-921-1_6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021281159

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22735948


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0303", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Macromolecular and Materials Chemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Particle Size", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptide Library", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Engineering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Stability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Structure, Tertiary", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "Protein Interactions Group, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gong", 
        "givenName": "Rui", 
        "id": "sg:person.01212247135.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212247135.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "Protein Interactions Group, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Weizao", 
        "id": "sg:person.0762165246.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762165246.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Frederick National Laboratory for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.418021.e", 
          "name": [
            "Protein Interactions Group, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dimitrov", 
        "givenName": "Dimiter S.", 
        "id": "sg:person.012247636637.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012247636637.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-1-59745-554-1_4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007639103", 
          "https://doi.org/10.1007/978-1-59745-554-1_4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-59745-554-1_4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007639103", 
          "https://doi.org/10.1007/978-1-59745-554-1_4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tibtech.2003.08.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009709651"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tibtech.2003.08.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009709651"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/363446a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018109154", 
          "https://doi.org/10.1038/363446a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m900769200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018843756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018849649", 
          "https://doi.org/10.1038/nbt1142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1142", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018849649", 
          "https://doi.org/10.1038/nbt1142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jmb.2004.09.033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020194106"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2009.07.044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021313623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tibtech.2005.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024143512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/341544a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030400388", 
          "https://doi.org/10.1038/341544a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0805297105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030515338"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0968-0004(01)01790-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031234727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.coph.2008.07.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033781424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jim.2004.04.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041333412"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045032676", 
          "https://doi.org/10.1038/nbt1127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt1127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045032676", 
          "https://doi.org/10.1038/nbt1127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m707078200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046907440"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jmb.2008.06.051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048203150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jmb.2008.06.051", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048203150"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.copbio.2007.04.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049298757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1742-4658.2008.06437.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052794769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/mabs.1.1.7480", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072305443"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012", 
    "datePublishedReg": "2012-01-01", 
    "description": "Most of the FDA-approved therapeutic monoclonal antibodies are full-size IgG molecules with a molecular weight of about 150 kDa. A major problem for such large molecules is their poor penetration into tissues (e.g., solid tumors) and poor or absent binding to regions on the surface of some molecules (e.g., on the HIV envelope glycoprotein) which are fully accessible only by molecules of smaller size. Therefore, much work especially during the last decade has been aimed at developing novel scaffolds of much smaller size and high stability. Immunoglobulin-based scaffolds including Fab (\u223c50 kD), ScFv (\u223c30 kD), and VH domain (termed domain antibody, dAb) (\u223c15 kD) have been well established. Recently, a new scaffold based on human IgG1 CH2 domain (\u223c15 kD) was also proposed (termed nanoantibody, nAb). Binders based on a CH2 scaffold could also confer some effector functions. Here, we describe the design, expression, purification, and characterization of engineered CH2 and VH domains.", 
    "editor": [
      {
        "familyName": "Voynov", 
        "givenName": "Vladimir", 
        "type": "Person"
      }, 
      {
        "familyName": "Caravella", 
        "givenName": "Justin A.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-61779-921-1_6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2724081", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2723791", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": {
      "isbn": [
        "978-1-61779-920-4", 
        "978-1-61779-921-1"
      ], 
      "name": "Therapeutic Proteins", 
      "type": "Book"
    }, 
    "name": "Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains", 
    "pagination": "85-102", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-61779-921-1_6"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6564f47a95a2cffe6142507189facb0a6c13ab8980314705caaef1a848e822be"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021281159"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22735948"
        ]
      }
    ], 
    "publisher": {
      "location": "Totowa, NJ", 
      "name": "Humana Press", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-61779-921-1_6", 
      "https://app.dimensions.ai/details/publication/pub.1021281159"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-15T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8684_00000256.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-1-61779-921-1_6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-921-1_6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-921-1_6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-921-1_6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-61779-921-1_6'


 

This table displays all metadata directly associated to this object as RDF triples.

190 TRIPLES      23 PREDICATES      56 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-61779-921-1_6 schema:about N1f5b40ddefd843a28a2f6a5548abc0b4
2 N26716fccf75f40f8b1d0a5d41d6b100d
3 N2f3f7b4fb8e14029a708ccd841866569
4 N5fb5a14cbd3240a186729454eadd75cf
5 N984c36d55f5140b38969632f4030571f
6 Na9dfaa19b188493f8e4a9a65a4ff4ed7
7 Nbcf63e2f6fda4fb3997bf76de4fde691
8 Nddfcc3d91a184441aa496b58eb24820c
9 Ne7428df648a2468ab31b568ef36a9c33
10 anzsrc-for:03
11 anzsrc-for:0303
12 schema:author N5edec66a9aa54b62ac40005f4771f29a
13 schema:citation sg:pub.10.1007/978-1-59745-554-1_4
14 sg:pub.10.1038/341544a0
15 sg:pub.10.1038/363446a0
16 sg:pub.10.1038/nbt1127
17 sg:pub.10.1038/nbt1142
18 https://doi.org/10.1016/j.bbrc.2009.07.044
19 https://doi.org/10.1016/j.copbio.2007.04.010
20 https://doi.org/10.1016/j.coph.2008.07.006
21 https://doi.org/10.1016/j.jim.2004.04.006
22 https://doi.org/10.1016/j.jmb.2004.09.033
23 https://doi.org/10.1016/j.jmb.2008.06.051
24 https://doi.org/10.1016/j.tibtech.2003.08.007
25 https://doi.org/10.1016/j.tibtech.2005.07.007
26 https://doi.org/10.1016/s0968-0004(01)01790-x
27 https://doi.org/10.1073/pnas.0805297105
28 https://doi.org/10.1074/jbc.m707078200
29 https://doi.org/10.1074/jbc.m900769200
30 https://doi.org/10.1111/j.1742-4658.2008.06437.x
31 https://doi.org/10.4161/mabs.1.1.7480
32 schema:datePublished 2012
33 schema:datePublishedReg 2012-01-01
34 schema:description Most of the FDA-approved therapeutic monoclonal antibodies are full-size IgG molecules with a molecular weight of about 150 kDa. A major problem for such large molecules is their poor penetration into tissues (e.g., solid tumors) and poor or absent binding to regions on the surface of some molecules (e.g., on the HIV envelope glycoprotein) which are fully accessible only by molecules of smaller size. Therefore, much work especially during the last decade has been aimed at developing novel scaffolds of much smaller size and high stability. Immunoglobulin-based scaffolds including Fab (∼50 kD), ScFv (∼30 kD), and VH domain (termed domain antibody, dAb) (∼15 kD) have been well established. Recently, a new scaffold based on human IgG1 CH2 domain (∼15 kD) was also proposed (termed nanoantibody, nAb). Binders based on a CH2 scaffold could also confer some effector functions. Here, we describe the design, expression, purification, and characterization of engineered CH2 and VH domains.
35 schema:editor Nc9f2de1bff484f5fa1ad1e65dcd429e0
36 schema:genre chapter
37 schema:inLanguage en
38 schema:isAccessibleForFree false
39 schema:isPartOf N8592e1cfc2a140e4b589da8d7c0479bc
40 schema:name Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains
41 schema:pagination 85-102
42 schema:productId N8c106479273e4183bd36083614128875
43 N979be4a7b1e04890a118e9d799ae3582
44 N9ef20d8fbfc54787809638ac3a292d90
45 Na437741501e74257a820fd76b9ecc6aa
46 schema:publisher N76546f49aba4443da787e1609adb5f3f
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021281159
48 https://doi.org/10.1007/978-1-61779-921-1_6
49 schema:sdDatePublished 2019-04-15T19:08
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N3c21c68298f14b3c91d5ebc4ec91601c
52 schema:url http://link.springer.com/10.1007/978-1-61779-921-1_6
53 sgo:license sg:explorer/license/
54 sgo:sdDataset chapters
55 rdf:type schema:Chapter
56 N0099684f08fb4857ae2a6566e0062e0a rdf:first sg:person.0762165246.36
57 rdf:rest N5889392d63574886b5e11d7096774ab5
58 N10f72ed5ed3a4cab9002ea1562784ab9 rdf:first N448fb29d909d4380962e97680f75b952
59 rdf:rest rdf:nil
60 N17b46bed702c416f8928357a6c1b81cb schema:familyName Voynov
61 schema:givenName Vladimir
62 rdf:type schema:Person
63 N1f5b40ddefd843a28a2f6a5548abc0b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Humans
65 rdf:type schema:DefinedTerm
66 N26716fccf75f40f8b1d0a5d41d6b100d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Antibodies, Monoclonal
68 rdf:type schema:DefinedTerm
69 N2f3f7b4fb8e14029a708ccd841866569 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Protein Structure, Tertiary
71 rdf:type schema:DefinedTerm
72 N3c21c68298f14b3c91d5ebc4ec91601c schema:name Springer Nature - SN SciGraph project
73 rdf:type schema:Organization
74 N448fb29d909d4380962e97680f75b952 schema:familyName Caravella
75 schema:givenName Justin A.
76 rdf:type schema:Person
77 N5889392d63574886b5e11d7096774ab5 rdf:first sg:person.012247636637.59
78 rdf:rest rdf:nil
79 N5edec66a9aa54b62ac40005f4771f29a rdf:first sg:person.01212247135.32
80 rdf:rest N0099684f08fb4857ae2a6566e0062e0a
81 N5fb5a14cbd3240a186729454eadd75cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Particle Size
83 rdf:type schema:DefinedTerm
84 N76546f49aba4443da787e1609adb5f3f schema:location Totowa, NJ
85 schema:name Humana Press
86 rdf:type schema:Organisation
87 N8592e1cfc2a140e4b589da8d7c0479bc schema:isbn 978-1-61779-920-4
88 978-1-61779-921-1
89 schema:name Therapeutic Proteins
90 rdf:type schema:Book
91 N8c106479273e4183bd36083614128875 schema:name doi
92 schema:value 10.1007/978-1-61779-921-1_6
93 rdf:type schema:PropertyValue
94 N979be4a7b1e04890a118e9d799ae3582 schema:name pubmed_id
95 schema:value 22735948
96 rdf:type schema:PropertyValue
97 N984c36d55f5140b38969632f4030571f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Protein Engineering
99 rdf:type schema:DefinedTerm
100 N9ef20d8fbfc54787809638ac3a292d90 schema:name readcube_id
101 schema:value 6564f47a95a2cffe6142507189facb0a6c13ab8980314705caaef1a848e822be
102 rdf:type schema:PropertyValue
103 Na437741501e74257a820fd76b9ecc6aa schema:name dimensions_id
104 schema:value pub.1021281159
105 rdf:type schema:PropertyValue
106 Na9dfaa19b188493f8e4a9a65a4ff4ed7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Immunoglobulin G
108 rdf:type schema:DefinedTerm
109 Nbcf63e2f6fda4fb3997bf76de4fde691 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Mutation
111 rdf:type schema:DefinedTerm
112 Nc9f2de1bff484f5fa1ad1e65dcd429e0 rdf:first N17b46bed702c416f8928357a6c1b81cb
113 rdf:rest N10f72ed5ed3a4cab9002ea1562784ab9
114 Nddfcc3d91a184441aa496b58eb24820c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Protein Stability
116 rdf:type schema:DefinedTerm
117 Ne7428df648a2468ab31b568ef36a9c33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Peptide Library
119 rdf:type schema:DefinedTerm
120 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
121 schema:name Chemical Sciences
122 rdf:type schema:DefinedTerm
123 anzsrc-for:0303 schema:inDefinedTermSet anzsrc-for:
124 schema:name Macromolecular and Materials Chemistry
125 rdf:type schema:DefinedTerm
126 sg:grant.2723791 http://pending.schema.org/fundedItem sg:pub.10.1007/978-1-61779-921-1_6
127 rdf:type schema:MonetaryGrant
128 sg:grant.2724081 http://pending.schema.org/fundedItem sg:pub.10.1007/978-1-61779-921-1_6
129 rdf:type schema:MonetaryGrant
130 sg:person.01212247135.32 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
131 schema:familyName Gong
132 schema:givenName Rui
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212247135.32
134 rdf:type schema:Person
135 sg:person.012247636637.59 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
136 schema:familyName Dimitrov
137 schema:givenName Dimiter S.
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012247636637.59
139 rdf:type schema:Person
140 sg:person.0762165246.36 schema:affiliation https://www.grid.ac/institutes/grid.418021.e
141 schema:familyName Chen
142 schema:givenName Weizao
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762165246.36
144 rdf:type schema:Person
145 sg:pub.10.1007/978-1-59745-554-1_4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007639103
146 https://doi.org/10.1007/978-1-59745-554-1_4
147 rdf:type schema:CreativeWork
148 sg:pub.10.1038/341544a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030400388
149 https://doi.org/10.1038/341544a0
150 rdf:type schema:CreativeWork
151 sg:pub.10.1038/363446a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018109154
152 https://doi.org/10.1038/363446a0
153 rdf:type schema:CreativeWork
154 sg:pub.10.1038/nbt1127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045032676
155 https://doi.org/10.1038/nbt1127
156 rdf:type schema:CreativeWork
157 sg:pub.10.1038/nbt1142 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018849649
158 https://doi.org/10.1038/nbt1142
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/j.bbrc.2009.07.044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021313623
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/j.copbio.2007.04.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049298757
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/j.coph.2008.07.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033781424
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/j.jim.2004.04.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041333412
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/j.jmb.2004.09.033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020194106
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/j.jmb.2008.06.051 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048203150
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/j.tibtech.2003.08.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009709651
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/j.tibtech.2005.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024143512
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/s0968-0004(01)01790-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1031234727
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1073/pnas.0805297105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030515338
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1074/jbc.m707078200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046907440
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1074/jbc.m900769200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018843756
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1111/j.1742-4658.2008.06437.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052794769
185 rdf:type schema:CreativeWork
186 https://doi.org/10.4161/mabs.1.1.7480 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072305443
187 rdf:type schema:CreativeWork
188 https://www.grid.ac/institutes/grid.418021.e schema:alternateName Frederick National Laboratory for Cancer Research
189 schema:name Protein Interactions Group, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA
190 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...